LeállítvaFázis nélkül
Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors
A legfontosabb adatok
- Ki végzi
- M.D. Anderson Cancer Center
- Hol
- Houston (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Leállítva
- Résztvevők
- 3 fő vett részt
- Kezdés
- 2022. nov. 17.
- Befejezés
- 2025. nov. 5.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Simulated Online Adaptive Planning
- Stereotactic MRI-guided adaptive radiotherapy-SMART
- A regiszteradat frissítve
- 2025. november 10.
- Miért állt le
- \<75 % participation
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 16 feltétel megnézéseKevesebb
Ki vehet részt
- Primary lung cancer or lung metastasis from another primary
- Central tumors ≤ 2 cm from any mediastinal critical structure (proximal bronchial tree, esophagus, heart, brachial plexus, major vessels, spinal cord, phrenic nerve, and recurrent laryngeal nerve
- Age ≥ 18 years
- Ability to understand and the willingness to sign a written informed consent
- Primary lung cancer or lung metastasis from another primary
- Central tumors ≤ 2 cm from any mediastinal critical structure (proximal bronchial tree, esophagus, heart, brachial plexus, major vessels, spinal cord, phrenic nerve, and recurrent laryngeal nerve
- Age ≥ 18 years
- Ability to understand and the willingness to sign a written informed consent
- Determined by two thoracic radiation oncologists to require > 10-15 fraction regimens if treated with CT-based, non-adaptive radiation therapy
Ki nem vehet részt
- Women who are pregnant. Women of childbearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control, abstinence) prior to study entry. Should a woman become pregnant or suspect she is pregnant while participating in this study, she must inform her treating physician immediately; Stage 2:
- Women who are pregnant. Women of childbearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control, abstinence) prior to study entry. Should a woman become pregnant or suspect she is pregnant while participating in this study, she must inform her treating physician immediately
- Inability to tolerate MR imaging (Ie. history of claustrophobia)
- Inability to tolerate MR imaging (Ie. history of claustrophobia)
- Contraindications to MR imaging (e.g. implanted metallic prostheses, defibrillators, stimulators, pacemakers, or neurotransmitters) per institutional policy on management of patients with internal and external medical devices
- Contraindications to MR imaging (e.g. implanted metallic prostheses, defibrillators, stimulators, pacemakers, or neurotransmitters) per institutional policy on management of patients with internal and external medical devices
Egyéb feltételek
- Stage I:
Helyszínek itt: Egyesült Államok
- M D Anderson Cancer CenterHouston, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
To learn if using MRI (magnetic resonance imaging) to guide radiation therapy can help to control central lung cancer. The results of the MRI-guided radiation therapy will be compared to conventional radiation therapy (guided by CT scans) during this study.
A vizsgálat 2 csoportja
- Stage I-(Simulated Online Adaptive Planning)A vizsgált kezelés
Participants will receive treatment with the conventional CT-based radiation therapy and receive additional MRI scans.
Kezelés: Simulated Online Adaptive Planning
- Stage II (Stereotactic MRI-guided adaptive radiotherapy-SMART)A vizsgált kezelés
Participants will receive treatment with the investigational MRI-guided radiation therapy.
Kezelés: Stereotactic MRI-guided adaptive radiotherapy-SMART
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- A regiszteradat frissítve
- 2025. november 10.